Write from this board Add posts Share
Loading the board
Loading the board
80 posts from @biogen, Jun 2025 to Sep 2026: a typical post earns 4 likes. That is more than 38% of the 275 other S&P 500 companies we hold content for. About 1 in 4 of their posts opens with a number.
| Post | Topic | Likes | Replies | Reposts | Score | Posted | Actions |
|---|---|---|---|---|---|---|---|
| @biogen#News: Today, we announced that the U.S. Food and Drug Administration (FDA) has granted Br… | Food tech | 16 | 1 | — | 10 | ||
| @biogen#News: We announced topline results from a Phase 2 study for an investigational drug targe… | Science | 10 | 0 | — | 4 | ||
| @biogen#News: We announced the completion of the acquisition of RayThera Inc. This acquisition ma… | Growth | 9 | 3 | — | 9 | ||
| @biogen#News: We’re attending the @alzassociation’s International Conference (#AAIC26) to share n… | Science | 9 | 0 | — | 3 | ||
| @biogen#News: Today, we announced an agreement to acquire RayThera Inc. With this deal, we aim to… | Revenue | 9 | 1 | — | 6 | ||
| @biogen#News: With @ucb_news, we announced data at the European Alliance of Associations for Rheu… | General | 9 | 0 | — | 3 | ||
| @biogen#News: Today, the FDA approved a new dosing regimen option for our spinal muscular atrophy… | General | 9 | 0 | — | 3 | ||
| @biogen#News: Together with Eisai, we announced that the FDA has approved a new delivery option f… | General | 8 | 0 | — | 2 | ||
| @biogen#News: Data from a Phase 2/3 study for SMA has been published in @NatureMedicine, explorin… | Science | 8 | 0 | — | 2 | ||
| @biogen#News: Together with @StokeTx, we announced the first patient has been dosed in a Phase 3 … | Science | 8 | 1 | — | 5 |